CompaniesAlmen Laboratories

Almen Laboratories

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

3,441

By Phase

PHASE4: 1PHASE3: 1

By Status

NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT00032435
NCT03064087
Hover over trial bars to see details

Recent Trials

NCT06449235Collaborator
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
PHASE4Not yet recruiting
938 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2025
NCT03064087Collaborator
Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples
N/AActive, not recruiting
500 participants
Started: Dec 29, 2017 · Completed: Nov 17, 2027
NCT00032435Collaborator
Homocysteine Study (HOST)
PHASE3Completed
2,003 participants
Started: May 31, 2001 · Completed: Sep 30, 2006
Almen Laboratories | Biotech Hunter | Biotech Hunter